🇺🇸 FDA
Patent

US 8703756

Synthetic procedure and cancer treatment with cisplatin derivatives

granted A61PA61P35/00

Quick answer

US patent 8703756 (Synthetic procedure and cancer treatment with cisplatin derivatives) held by THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS
Grant date
Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00